ProCE Banner Activity

Critical Actions in Emergency Medicine: Timely Diagnosis and Treatment of CAR T-Cell‒ and Bispecific Antibody‒Related AEs in Multiple Myeloma


Download these slides to learn more about essential strategies for emergency medicine teams to screen for and manage adverse events in patients with multiple myeloma who have received CAR T-cell therapy or bispecific antibody treatment and are seeking care in the emergency department.

Released: January 19, 2024



Thomas G. Martin

Thomas G. Martin, MD

Clinical Professor of Medicine
Associate Chief, Hematology
Co-Director, Myeloma Program
University of California,
San Francisco Medical Center
San Francisco, California

Noopur Raje

Noopur Raje, MD

Center for Multiple Myeloma
Rita Kelly Chair in Oncology
Massachusetts General Hospital Cancer Center
Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner


Supported by an education grant from Janssen Biotech, Inc. administered by Janssen Scientific Affairs, LLC.

Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC